• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性 HIV 感染者和非感染者的阿尔茨海默病血浆生物标志物。

Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.

机构信息

Department of Epidemiology and Biostatistics, Temple University, Philadelphia, Pennsylvania.

Department of Neurology, State University of New York Downstate Health Sciences University, Brooklyn.

出版信息

JAMA Netw Open. 2023 Nov 1;6(11):e2344194. doi: 10.1001/jamanetworkopen.2023.44194.

DOI:10.1001/jamanetworkopen.2023.44194
PMID:38019518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10687654/
Abstract

IMPORTANCE

Blood-based biomarkers associated with increased risk of Alzheimer disease (AD) are understudied in people living with and without HIV, particularly women.

OBJECTIVE

To determine whether baseline or 1-year changes in plasma amyloid-β40 (Aβ40), Aβ42, ratio of Aβ42 to Aβ40, total tau (t-tau), phosphorylated tau 231 (p-tau231), glial fibrillary acidic protein (GFAP), and/or neurofilament light chain (NFL) are associated with neuropsychological performance (NP) among women living with HIV (WLWH) and women living without HIV (WLWOH).

DESIGN, SETTING, AND PARTICIPANTS: This longitudinal, prospective, cohort study with 1-year repeated clinical measures (NP only measured once) and biospecimen collection occurred between 2017 and 2019. Participants were women aged 40 years or older from 10 clinical research sites in cities across the US that were part of the Women's Interagency HIV Study. Data analysis was conducted from April to December 2022.

EXPOSURE

Laboratory-confirmed HIV status and AD biomarkers.

MAIN OUTCOMES AND MEASURES

Sociodemographically adjusted NP T-scores (attention and working memory, executive function, processing speed, memory, learning, verbal fluency, motor function, and global performance) were the primary outcomes. Baseline and 1-year fasting plasma Aβ40, Aβ42, t-tau, p-tau231, GFAP, and NFL levels were measured and analyzed using multivariable linear regression.

RESULTS

The study consisted of 307 participants (294 aged ≥50 years [96%]; 164 African American or Black women [53%]; 214 women with a high school education or higher [70%]; 238 women who were current or former smokers [78%]; and 236 women [77%] who were overweight or obese [body mass index >25]) including 209 WLWH and 98 WLWOH. Compared with WLWOH at baseline, WLWH performed worse on learning (mean [SD] T-score 47.8 [11.3] vs 51.4 [10.5]), memory (mean [SD] T-score 48.3 [11.6] vs 52.4 [10.2]), verbal fluency (mean [SD] T-score 48.3 [9.8] vs 50.7 [8.5]), and global (mean [SD] T-score 49.2 [6.8] vs 51.1 [5.9]) NP assessments. Baseline median Aβ40, GFAP, and NFL levels were higher among WLWH vs WLWOH. There were no differences in 1-year biomarker change by HIV serostatus. Lower learning, memory, and motor NP were associated with 1-year Aβ40 increase; lower learning and motor with Aβ42 increase; lower motor with p-tau231 increase; and lower processing speed, verbal fluency and motor with NFL increase in the entire sample. Among WLWH, a 1-year increase in Aβ40 from baseline to follow-up was associated with worse learning, memory, and global NP; a 1-year increase in t-tau with worse executive function; and a 1-year increase in NFL with worse processing speed. Among WLWOH, a 1-year increase in Aβ40 and Aβ42 were associated with poorer memory performance and NFL was associated with poorer motor performance.

CONCLUSIONS AND RELEVANCE

These findings suggest that increases in certain plasma AD biomarkers are associated with NP in WLWH and WLWOH and may be associated with later onset of AD, and measuring these biomarkers could be a pivotal advancement in monitoring aging brain health and development of AD among women with and without HIV.

摘要

重要性

在患有和不患有 HIV 的人群中,与阿尔茨海默病(AD)风险增加相关的血液生物标志物研究较少,尤其是女性。

目的

确定基线或 1 年血浆淀粉样蛋白-β40(Aβ40)、Aβ42、Aβ42 与 Aβ40 的比值、总 tau(t-tau)、磷酸化 tau231(p-tau231)、神经胶质纤维酸性蛋白(GFAP)和/或神经丝轻链(NFL)的变化是否与 HIV 阳性女性(WLWH)和无 HIV 女性(WLWOH)的神经心理学表现(NP)相关。

设计、地点和参与者:这是一项纵向、前瞻性队列研究,在 2017 年至 2019 年间进行了 1 年的重复临床测量(仅一次测量 NP)和生物样本采集。参与者为来自美国各地 10 个临床研究地点的年龄在 40 岁或以上的女性,这些研究地点是妇女艾滋病研究机构(Women's Interagency HIV Study)的一部分。数据分析于 2022 年 4 月至 12 月进行。

暴露情况

实验室确认的 HIV 状况和 AD 生物标志物。

主要结果和测量

调整了社会人口统计学的 NP T 评分(注意力和工作记忆、执行功能、处理速度、记忆、学习、语言流畅性、运动功能和整体表现)是主要结果。测量并使用多变量线性回归分析了基线和 1 年的空腹血浆 Aβ40、Aβ42、t-tau、p-tau231、GFAP 和 NFL 水平。

结果

该研究包括 307 名参与者(294 名年龄≥50 岁[96%];164 名非裔美国或黑人女性[53%];214 名具有高中或以上学历的女性[70%];238 名当前或曾经吸烟的女性[78%];236 名超重或肥胖的女性[体重指数>25]),包括 209 名 WLWH 和 98 名 WLWOH。与 WLWOH 相比,WLWH 在学习(平均[标准差]T 评分 47.8[11.3]vs 51.4[10.5])、记忆(平均[标准差]T 评分 48.3[11.6]vs 52.4[10.2])、语言流畅性(平均[标准差]T 评分 48.3[9.8]vs 50.7[8.5])和整体(平均[标准差]T 评分 49.2[6.8]vs 51.1[5.9])NP 评估方面表现更差。与 WLWOH 相比,WLWH 的基线中位数 Aβ40、GFAP 和 NFL 水平更高。HIV 血清状态对 1 年生物标志物变化没有影响。整个样本中,1 年 Aβ40 增加与学习、记忆和运动 NP 下降有关;1 年 Aβ42 增加与学习和运动下降有关;1 年 p-tau231 增加与运动下降有关;1 年 NFL 增加与处理速度、语言流畅性和运动下降有关。在 WLWH 中,从基线到随访时 Aβ40 增加 1 年与学习、记忆和整体 NP 下降有关;t-tau 增加 1 年与执行功能下降有关;NFL 增加 1 年与处理速度下降有关。在 WLWOH 中,Aβ40 和 Aβ42 增加 1 年与记忆功能下降有关,NFL 与运动功能下降有关。

结论和相关性

这些发现表明,某些血浆 AD 生物标志物的增加与 WLWH 和 WLWOH 的 NP 相关,可能与 AD 的发病较晚有关,测量这些生物标志物可能是监测 HIV 阳性和阴性女性大脑衰老健康和 AD 发展的重要进展。

相似文献

1
Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.女性 HIV 感染者和非感染者的阿尔茨海默病血浆生物标志物。
JAMA Netw Open. 2023 Nov 1;6(11):e2344194. doi: 10.1001/jamanetworkopen.2023.44194.
2
Serum NFL and neuropsychological performance over ∼8 years in women with and without HIV: a longitudinal repeated measures study.有和未感染艾滋病毒女性约8年期间的血清神经丝轻链蛋白水平与神经心理表现:一项纵向重复测量研究
EClinicalMedicine. 2025 Jan 21;80:103052. doi: 10.1016/j.eclinm.2024.103052. eCollection 2025 Feb.
3
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.
4
Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity.糖尿病与超重或肥胖个体中的阿尔茨海默病血液生物标志物与认知
JAMA Netw Open. 2025 Feb 3;8(2):e2458149. doi: 10.1001/jamanetworkopen.2024.58149.
5
Olfaction and Plasma Biomarkers of Alzheimer Disease and Neurodegeneration in the Atherosclerosis Risk in Communities Study.社区动脉粥样硬化风险研究中阿尔茨海默病和神经退行性变的嗅觉与血浆生物标志物
Neurology. 2025 Jun 10;104(11):e213706. doi: 10.1212/WNL.0000000000213706. Epub 2025 May 15.
6
APOE4, Blood Neurodegenerative Biomarkers, and Cognitive Decline in Community-Dwelling Older Adults.载脂蛋白E4、血液神经退行性生物标志物与社区居住老年人的认知衰退
JAMA Netw Open. 2025 May 1;8(5):e258903. doi: 10.1001/jamanetworkopen.2025.8903.
7
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用:系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
8
Short-term variability of Alzheimer's disease plasma biomarkers in a mixed memory clinic cohort.混合记忆门诊队列中阿尔茨海默病血浆生物标志物的短期变异性
Alzheimers Res Ther. 2025 Jan 21;17(1):26. doi: 10.1186/s13195-024-01658-7.
9
Timing of changes in Alzheimer's disease plasma biomarkers as assessed by amyloid and tau PET clocks.通过淀粉样蛋白和tau PET时钟评估阿尔茨海默病血浆生物标志物变化的时间。
medRxiv. 2024 Nov 14:2024.10.25.24316144. doi: 10.1101/2024.10.25.24316144.
10
Sex differences in the relationships between 24-h rest-activity patterns and plasma markers of Alzheimer's disease pathology.24小时休息-活动模式与阿尔茨海默病病理血浆标志物之间关系的性别差异。
Alzheimers Res Ther. 2024 Dec 30;16(1):277. doi: 10.1186/s13195-024-01653-y.

引用本文的文献

1
Serum NFL and neuropsychological performance over ∼8 years in women with and without HIV: a longitudinal repeated measures study.有和未感染艾滋病毒女性约8年期间的血清神经丝轻链蛋白水平与神经心理表现:一项纵向重复测量研究
EClinicalMedicine. 2025 Jan 21;80:103052. doi: 10.1016/j.eclinm.2024.103052. eCollection 2025 Feb.
2
Plasma Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers of Cognitive Decline in People With Human Immunodeficiency Virus.血浆神经丝轻链和胶质纤维酸性蛋白作为人类免疫缺陷病毒感染者认知功能下降的生物标志物。
J Infect Dis. 2025 Apr 15;231(4):946-956. doi: 10.1093/infdis/jiae623.
3
Application status and prospects of multimodal EEG-fMRI in HIV-associated neurocognitive disorders.多模态脑电图-功能磁共振成像在HIV相关神经认知障碍中的应用现状与前景
Front Neurol. 2024 Dec 5;15:1479197. doi: 10.3389/fneur.2024.1479197. eCollection 2024.
4
Biomarkers Unveiling the Interplay of Mind, Nervous System, and Immunity.生物标志物揭示心智、神经系统和免疫系统的相互作用。
Methods Mol Biol. 2025;2868:73-90. doi: 10.1007/978-1-0716-4200-9_5.
5
Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study.原发 HIV 感染无症状患者的血清和脑脊液生物标志物:一项随机研究。
Brain. 2024 Nov 4;147(11):3742-3750. doi: 10.1093/brain/awae271.
6
Error in Byline.署名错误。
JAMA Netw Open. 2024 Jan 2;7(1):e2353563. doi: 10.1001/jamanetworkopen.2023.53563.

本文引用的文献

1
Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.人类免疫缺陷病毒感染者中枢神经系统并发症的生物型:病毒学、免疫学和神经病理学。
J Infect Dis. 2023 Mar 17;227(Suppl 1):S3-S15. doi: 10.1093/infdis/jiac370.
2
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
3
Plasma Aβ42/Aβ40 Ratios in Older People With Human Immunodeficiency Virus.老年人中人类免疫缺陷病毒感染者的血浆 Aβ42/Aβ40 比值。
Clin Infect Dis. 2023 May 24;76(10):1776-1783. doi: 10.1093/cid/ciad001.
4
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.阿尔茨海默病连续体中的血浆 Aβ42/40 比值、p-tau181、GFAP 和 NfL:AIBL 队列的横断面和纵向研究。
Alzheimers Dement. 2023 Apr;19(4):1117-1134. doi: 10.1002/alz.12724. Epub 2022 Jul 21.
5
Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration.基于血液和神经生理学标志物在阿尔茨海默病和额颞叶变性鉴别诊断中的分类准确性。
Alzheimers Res Ther. 2022 Oct 13;14(1):155. doi: 10.1186/s13195-022-01094-5.
6
Blood biomarkers for HIV infection with focus on neurologic complications-A review.HIV 感染的血液生物标志物——关注神经并发症——综述。
Acta Neurol Scand. 2022 Jul;146(1):56-60. doi: 10.1111/ane.13629. Epub 2022 Apr 26.
7
Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature.基于生物流体的阿尔茨海默病相关病理生物标志物:文献综述与更新。
Alzheimers Dement. 2022 Sep;18(9):1687-1693. doi: 10.1002/alz.12618. Epub 2022 Feb 25.
8
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.治疗后人类免疫缺陷病毒感染患者脑脊液和血浆神经丝轻链蛋白的相关性:来自 COBRA 研究的结果。
J Neurovirol. 2022 Feb;28(1):54-63. doi: 10.1007/s13365-021-01026-3. Epub 2021 Dec 7.
9
Body Mass Index and Leptin Are Related to Cognitive Performance Over 10 Years in Women With and Without HIV Infection.体重指数和瘦素与 HIV 感染和未感染女性 10 年内的认知表现相关。
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1126-e1135. doi: 10.1210/clinem/dgab759.
10
HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance.在原发性 HIV 感染期间,HIV 疾病动力学与炎症和中枢神经系统损伤标志物及其与认知表现的关系。
J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):183-190. doi: 10.1097/QAI.0000000000002832.